Pablo
Pelegrin Vivancos
Catedraticos de Universidad
University of Freiburg
Friburgo de Brisgovia, AlemaniaPublicacións en colaboración con investigadores/as de University of Freiburg (2)
2021
-
Identification of an ASC oligomerization inhibitor for the treatment of inflammatory diseases
Cell Death and Disease, Vol. 12, Núm. 12
2020
-
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
Brain : a journal of neurology, Vol. 143, Núm. 5, pp. 1414-1430